1 year return (CAGR)
-37.47%
Genelux Corporation Common Stock Exchange (NASDAQ, USD)
GNLX
2.53
-0.07 (-2.76%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-52.27%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
111.76M
Price/Sales
13969.50
Ent value
112.66M
Price/Book
6.94
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
8.43%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.61 |
| Daily high | 2.61 |
| Daily low | 2.40 |
| Daily Volume | 203K |
| All-time high | 38.00 |
| 1y analyst estimate | 19.00 |
| Beta | 0.56 |
| EPS (TTM) | -0.75 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 Apr 2026 |
Downside potential
Loading...
Downside potential data
| GNLX | S&P500 | |
| Current price drop from All-time high | -93.34% | -1.96% |
| Highest price drop | -95.74% | -56.47% |
| Date of highest drop | 5 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -74.53% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 812 days | 1805 days |
News
